This collaboration is focussed on aiding the general manufacturing of ventilators by addressing particular areas of the provision chain, IT system and manufacturing processes.
- Last Updated: April 30, 2020, 12:32 PM IST
- Edited by: Anirudh SK
MG Motor India has joined palms with Vadodara-based MAX Ventilator, part of A.B. Industries. Founded in 1995, A.B. Industries has been manufacturing ventilators for the previous 25 years. Max Ventilator is among the many high 25 ventilator manufacturers on the planet and caters primarily to the non-public hospitals.
This collaboration is focussed on aiding the general manufacturing of ventilators by addressing particular areas of the provision chain, IT system and manufacturing processes. The manufacturing capability can be elevated 5 instances to 300 ventilators per 30 days in Phase I which must be accomplished throughout the subsequent eight weeks. In Phase II, the manufacturing capability could be enhanced as much as 1,000 ventilators per 30 days, relying upon the demand, particularly from the federal government hospitals to assist meet the scarcity of the life-saving medical units within the nation.
Speaking on the affiliation, Rajeev Chaba, President & Managing Director, MG Motor India, mentioned, “At MG, we are committed to supporting our country’s fight against Covid-19 crisis. We understand that ventilators are the most critical requirement at this time, and we would do our best to enhance ventilator production. The collaboration comes as a result of aligned core values of both organisations and is designed to work towards the common goal of serving the communities around where our operations are based”
Ashok Patel, MD of A.B. Industries – MAX Ventilator, mentioned, “In such times of need, it is an admirable thing for all those capable to come forward and help in some way. As a manufacturing company of respiratory ventilators, this collaboration with MG Motor will help us to scale up the production with our teams working together hand in hand. Collaborations like these will guarantee that we meet the requirements to treat the rising COVID-19 cases in India.”